Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Drug Metabolism: Phase I Reactions
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Opioid Receptors: Overview
Drug Metabolism: Phase II Reactions
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Aug 7, 2025

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
Jacob Thomsen1, Russell A Wilke2, Matthew Jahraus2
1University of South Dakota Sanford School of Medicine, Sioux Falls, South Dakota.
Automated clinical decision support is evolving to prevent drug-gene interactions (DGIs), particularly those involving CYP2D6 gene variations. This approach aims to optimize opioid prescribing in post-operative care.
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
10:13Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
Published on: November 8, 2024
Area of Science:
Background:
Conclusions: